Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02975505 · ClinicalTrials.gov registry record · NA
Pilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT02975505 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 108 participants.
The verdict
NCT02975505, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
The transition from chronic kidney disease (CKD) to end-stage renal disease ESRD is a vulnerable and challenging period of time for patients and providers. Suboptimal control of blood pressure is known to be common in patients with the advanced stages of CKD, and may contribute to their elevated risk of progression to ESRD, cardiovascular morbidity, and mortality. This proposal is a pilot randomized controlled trial designed to test whether intensive home blood pressure lowering is feasible and safe in patients with advanced CKD as they transition to ESRD.
Interventions
- OTHER Strict blood pressure control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2017-02-10 |
| Est. Completion | 2021-07-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02975505
The ClinicalTrials.gov registry entry for NCT02975505 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Strict blood pressure control is the first listed.
NCT02975505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02975505 about?
NCT02975505 is a clinical study titled "Pilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD". The transition from chronic kidney disease (CKD) to end-stage renal disease ESRD is a vulnerable and challenging period of time for patients and providers. Suboptimal control of blood pressure is known to be common in patients with the advanced stages of CKD, and may contribute to their elevated ris...
What is the current status of trial NCT02975505?
This trial is currently terminated. It is a NA study. The enrollment target is 108 participants. The study started on 2017-02-10. Estimated completion is 2021-07-18.
What interventions are being tested in trial NCT02975505?
The interventions under investigation include: Strict blood pressure control (OTHER).
Who is sponsoring clinical trial NCT02975505?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.